CHARLES NEMEROFF: Open Payments
NPI 1326228347 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$62,803 in 20 payments from 6 companies in 2025. Trend: 2023 $109,177 · 2024 $76,154 · 2025 $62,803
Consulting: $46,000Honoraria: $14,400Travel & lodging: $1,784Speaker / faculty: $500Food & beverage: $119
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 2 | $25,000 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $17,500 |
| H. Lundbeck A S | 1 | $14,400 |
| Supernus Pharmaceuticals, Inc. | 1 | $3,500 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $1,903 |
| Almatica Pharma LLC | 1 | $500 |
Products named: CAPLYTA, REXULTI, LOREEV XR.
Industry payments across TX — which companies pay providers there.
